- Disease: Monkeypox virus infection
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To assess the immunogenicity, reactogenicity and safety of the VAC?6 vaccine in healthy volunteers aged 18-60 years
- Number of participants enrolled: 334
- Study enrolling from to
Study Data
- Adults
- General population
- Monkeypox virus
- Monkeypox virus infection
- Vaccination
- Pharmacological intervention
- VAC∆6
External Links
Other information
Funders:
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to